Renaissance Capital logo

dplo News

US IPO Pricing Recap: Mixed returns among week's 7 IPOs despite market selloff

7 IPOs collectively raised just over $1 billion in a volatile week for stocks. The IPO market has seen 223 deals year-to-date, surpassing 2014's full-year post-bubble record of 222 (post to Twitter). Marketing SaaS provider HubSpot (HUBS) was the only IPO to price above the midpoint, and it and Diplomat Pharmacy (DPLO) posted the top returns for...read more

Diplomat Pharmacy prices IPO at $13, below the range

Diplomat Pharmacy, which operates the fourth largest specialty pharmacy in the US, raised $173 million by offering 13.3 million shares at $13, below the range of $14 to $16. Diplomat Pharmacy plans to list on the NYSE under the symbol DPLO. Credit Suisse, Morgan Stanley, J.P. Morgan and Wells Fargo Securities acted as lead managers on the deal....read more

8 US IPOs planned for the week of October 6, including hot tech, global finance and a restaurant/arcade

Eight initial public offerings are expected to raise $1.3 billion during the week of October 6, 2014, representing a well-rounded group of tech, finance, health care, consumer, and energy IPOs. After uninspiring performance from ...read more

Specialty drug distributor Diplomat Pharmacy sets terms for $200 million IPO

Diplomat Pharmacy, which operates the fourth largest specialty pharmacy in the US, announced terms for its IPO on Monday. The Flint, MI-based company plans to raise $200 million by offering 13.3 million shares (25% insider) at a price range of $14 to $16. At the midpoint of the proposed range, it would command a fully diluted market value of $814 million. Diplomat distributes...read more